CLOSE

Specials

I agree We use cookies on this website to enhance your user experience. By clicking any link on this page you are giving your consent for us to set cookies. More info

Skip to: Curated Story Group 1
Life Sciences Review
US
EUROPE
APAC
CANADA

About Us

Conference

Partner With Us

  • US
    • EUROPE
    • APAC
    • CANADA
    • LATAM
  • Drug Discovery
    Antibodies
    BioTech
    Cell and Gene Therapy
    Clinical Trial
    Drug Discovery and Development
    Life Science AI
    Regenerative Medicine
    Therapeutics
  • Biomanufacturing
    Biomanufacturing
    Bioprocessing
    Blood Bank
    CDMO
    Clinical Laboratory
    CRO
    Life Science Testing
    Skin Care
    Supplements
  • Business Services
    Life Science Consulting
    Life Science Facility Service
    Life Science Financial Services
    Life Science Marketing
    Life Science Recruitment Firms
    Pharma Wholesale and Distribution
    Pharmacy Management
    Regulatory and Compliance
    Regulatory Services
  • Leadership Perspectives
  • Innovation Insights
  • Research
  • News
  • Magazines
  • CXO Awards
×
#

Life Science Review Weekly Brief

Be first to read the latest tech news, Industry Leader's Insights, and CIO interviews of medium and large enterprises exclusively from Life Science Review

Subscribe

loading

Thank you for Subscribing to Life Science Review Weekly Brief

A featured contribution from Leadership Perspectives: a curated forum reserved for leaders nominated by our subscribers and vetted by our Life Sciences Review Advisory Board.

Applied DNA Sciences Inc

Judy Murrah, CIO

DNA Infusion-Providing an Identity and Voice to Pharmaceuticals

Judy Murrah

The Internet of Things is focused on smart things. “Unintelligent” things such as pharmaceuticals need a voice to ensure that they are real, safe, and traceable. With many devastating stories in the media every day, at unmeasurable global scale, one thing we can be sure… our lives depend on it!


Botanically-derived DNA as an information carrier, supported by mobile readers and an online authentication platform, can be a transformational solution. This Identity of Things (IDoT) concept can be constructed simply or it can be multi-layered with multi-factor authentication.


SigNature® DNA forms the simple, forensic ingredient of identity. Just a molecule of DNA with a known sequence is assigned a meaning related to the item it marks (e.g., source, owner, time period or other). It is stored in a database available for future authentication reference. A DNA reader is used in a lab or in the field to extract identity information from the DNA. Checked and updated against a database, its contextual attributes could include such indicators as time and geo-location stamp, authenticator and other relevant characteristics captured from the physical object or transaction. Each authentication adds currency to the item’s value by reinforcing its authenticity and traceability throughout its lifecycle.


Taking this example further, a multi- DNA version of this concept can be called a “product genome”. SigNature DNA can be adhered to or embedded in each of the following layers of the product: a tablet’s Active Pharmaceutical Ingredient (API), an excipient, the tablet labeling ink; in the plastic package, and in packaging print inks. Combining these DNA codes, a multi-factor identity of a given product is formed, all added seamlessly as part of each existing manufacturing process.


The pharmaceutical now has a product genome, which can be authenticated “CSI-like” against internet-connected databases as it travels through the value chain.


Botanically-derived DNA as an information carrier, supported by mobile readers and an online authentication platform, can be a transformational solution


As this platform emerges, the innovation is in the way we use it to communicate transparently about such endeavors as material sourcing, manufacturing origin, and ingredient traceability. Compelling to the CIO, as the world of biotechnology and information technology collide, it yields a new progressive way to secure and share encrypted information. The floodgates have opened. Begin now to recruit the skills, build the processes and infrastructure, and gain experience through field trials.


Proof is in the cotton supply chain. Over 100 million pounds of American cotton have been given a SigNature DNA identity during ginning in California’s San Joaquin Valley. On its journey, it became yarn, fabric and finished goods in Asia. Then it traveled back to the United States onto stores shelves where the DNA identity applied to the original cotton is verified and traced. Everyone wins—the consumer, retail brands, farmers, and all members of the supply chain— embracing a new way to ensure a simple cotton bud had an identity and voice in today’s commercial world.


The articles from these contributors are based on their personal expertise and viewpoints, and do not necessarily reflect the opinions of their employers or affiliated organizations.
The Leadership Perspectives forum brings together voices shaping the future of life sciences. It features leaders who are advancing change across the industry through strategic leadership and applied insight.
EDITOR'S CHOICE
  • Willis Towers Watson

    ICON [NASDAQ: ICLR]

    The Significant Increase in Demand for Clinical Research Associates (CRAs)

    Helen Yeardley, Executive Vice President, ICON [NASDAQ: ICLR]

  • Willis Towers Watson

    PacBio [NASDAQ: PACB]

    The Talent - Culture Continuum: How to Manage an Innovation Culture Amid Growth and Change

    Alvin Hom, Head of Global Talent Acquisition, PacBio [NASDAQ: PACB]

  • Willis Towers Watson

    Repligen Corp [NASDAQ: RGEN]

    Gene Therapy-Therapeutic Viral Vectors; Manufacturing, Challenges, and Innovation

    Rachel Legmann, PhD, Senior Director of Technology, Gene Therapy, Repligen Corp

  • Willis Towers Watson

    Ionis Pharmaceuticals [NASDAQ: IONS]

    Bridging the Diversity Divide

    Victoria Sanjurjo, Medical Director, Clinical Development, Ionis Pharmaceuticals, Inc [NASDAQ: IONS]

Life Sciences Review
Follow on LinkedIn

About

  • Home
  • About Us
  • Partner With Us

Stay Connected

  • Subscribe
  • Newsletter
  • Sitemap

Contact Us

  • editor@lifesciencesreview.com
  • sales@lifesciencesreview.com
  • marketing@lifesciencesreview.com

Legal

  • Editorial Policy
  • Privacy Policy
  • Terms of Use

© 2026 Life Sciences Review. All rights reserved. Headquartered in Fort Lauderdale, FL, USA.

This content is copyright protected

However, if you would like to share the information in this article, you may use the link below:

https://genomics-europe.lifesciencesreview.com/cioviewpoint/dna-infusionproviding-an-identity-and-voice-to-pharmaceuticals-nwid-308.html